메뉴 건너뛰기




Volumn 2012, Issue , 2012, Pages

Cellular-based immunotherapies for patients with glioblastoma multiforme

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BEVACIZUMAB; GLIOBLASTOMA ASSOCIATED ANTIGEN; TEMOZOLOMIDE; UNCLASSIFIED DRUG; VIRUS ANTIGEN; CANCER VACCINE; CELL EXTRACT; CYTOKINE; DACARBAZINE; DRUG DERIVATIVE;

EID: 84863270634     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/764213     Document Type: Review
Times cited : (22)

References (153)
  • 4
    • 33645986455 scopus 로고    scopus 로고
    • Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial
    • Stummer W., Pichlmeier U., Meinel T., Wiestler O. D., Zanella F., Reulen H. J., Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial The Lancet Oncology 2006 7 5 392 401
    • (2006) The Lancet Oncology , vol.7 , Issue.5 , pp. 392-401
    • Stummer, W.1    Pichlmeier, U.2    Meinel, T.3    Wiestler, O.D.4    Zanella, F.5    Reulen, H.J.6
  • 5
    • 70449523002 scopus 로고    scopus 로고
    • Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas
    • Stockhammer F., Misch M., Horn P., Koch A., Fonyuy N., Plotkin M., Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas Acta Neurochirurgica 2009 151 11 1377 1383
    • (2009) Acta Neurochirurgica , vol.151 , Issue.11 , pp. 1377-1383
    • Stockhammer, F.1    Misch, M.2    Horn, P.3    Koch, A.4    Fonyuy, N.5    Plotkin, M.6
  • 6
    • 33644787355 scopus 로고    scopus 로고
    • Gliadel® wafer in initial surgery for malignant glioma: Long-term follow-up of a multicenter controlled trial
    • DOI 10.1007/s00701-005-0707-z
    • Westphal M., Ram Z., Riddle V., Hilt D., Bortey E., Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial Acta Neurochirurgica 2006 148 3 269 275 (Pubitemid 43341024)
    • (2006) Acta Neurochirurgica , vol.148 , Issue.3 , pp. 269-275
    • Westphal, M.1    Ram, Z.2    Riddle, V.3    Hilt, D.4    Bortey, E.5
  • 8
    • 0027415401 scopus 로고
    • Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme
    • Kreth F. W., Warnke P. C., Scheremet R., Ostertag C. B., Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme Journal of Neurosurgery 1993 78 5 762 766 (Pubitemid 23121918)
    • (1993) Journal of Neurosurgery , vol.78 , Issue.5 , pp. 762-766
    • Kreth, F.W.1    Warnke, P.C.2    Scheremet, R.3    Ostertag, C.B.4
  • 9
    • 0034916566 scopus 로고    scopus 로고
    • The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours - A prospective study
    • DOI 10.1007/s007010170058
    • Kreth F. W., Muacevic A., Medele R., Bise K., Meyer T., Reulen H. J., The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumoursa prospective study Acta Neurochirurgica 2001 143 6 539 546 (Pubitemid 32662388)
    • (2001) Acta Neurochirurgica , vol.143 , Issue.6 , pp. 539-546
    • Kreth, F.W.1    Muacevic, A.2    Medele, R.3    Bise, K.4    Meyer, T.5    Reulen, H.-J.6
  • 10
    • 35649001325 scopus 로고    scopus 로고
    • Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas
    • DOI 10.1002/ijc.23020
    • Grasbon-Frodl E. M., Kreth F. W., Ruiter M., Schnell O., Bise K., Felsberg J., Reifenberger G., Tonn J. C., Kretzschmar H. A., Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas International Journal of Cancer 2007 121 11 2458 2464 (Pubitemid 350022415)
    • (2007) International Journal of Cancer , vol.121 , Issue.11 , pp. 2458-2464
    • Grasbon-Frodl, E.M.1    Kreth, F.W.2    Ruiter, M.3    Schnell, O.4    Bise, K.5    Felsberg, J.6    Reifenberger, G.7    Tonn, J.-C.8    Kretzschmar, H.A.9
  • 15
    • 45849146166 scopus 로고    scopus 로고
    • 'Recurrent' glioblastoma multiforme, when should we reoperate?
    • DOI 10.1080/02688690802182256, PII 793649736
    • Barbagallo G. M. V., Jenkinson M. D., Brodbelt A. R., 'Recurrent' glioblastoma multiforme, when should we reoperate? British Journal of Neurosurgery 2008 22 3 452 455 (Pubitemid 351878614)
    • (2008) British Journal of Neurosurgery , vol.22 , Issue.3 , pp. 452-455
    • Barbagallo, G.M.V.1    Jenkinson, M.D.2    Brodbelt, A.R.3
  • 16
    • 42049111663 scopus 로고    scopus 로고
    • Repeated surgery for glioblastoma multiforme: Only in combination with other salvage therapy
    • Mandl E. S., Dirven C. M. F., Buis D. R., Postma T. J., Vandertop W. P., Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy Surgical Neurology 2008 69 5 506 509
    • (2008) Surgical Neurology , vol.69 , Issue.5 , pp. 506-509
    • Mandl, E.S.1    Dirven, C.M.F.2    Buis, D.R.3    Postma, T.J.4    Vandertop, W.P.5
  • 17
    • 48749133554 scopus 로고    scopus 로고
    • Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas
    • Combs S. E., Bischof M., Welzel T., Hof H., Oertel S., Debus J., Schulz-Ertner D., Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas Journal of Neuro-Oncology 2008 89 2 205 210
    • (2008) Journal of Neuro-Oncology , vol.89 , Issue.2 , pp. 205-210
    • Combs, S.E.1    Bischof, M.2    Welzel, T.3    Hof, H.4    Oertel, S.5    Debus, J.6    Schulz-Ertner, D.7
  • 19
    • 78649628169 scopus 로고    scopus 로고
    • FDA accelerated approval benefits glioblastoma
    • Cloughesy T., FDA accelerated approval benefits glioblastoma The Lancet Oncology 2010 11 12 1120
    • (2010) The Lancet Oncology , vol.11 , Issue.12 , pp. 1120
    • Cloughesy, T.1
  • 23
    • 33750432843 scopus 로고    scopus 로고
    • Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: Phase II study from Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
    • DOI 10.1038/sj.bjc.6603376, PII 6603376
    • Brandes A. A., Tosoni A., Cavallo G., Bertorelle R., Gioia V., Franceschi E., Biscuola M., Blatt V., Crin L., Ermani M., Temozolomide 3weeks on and 1week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO) British Journal of Cancer 2006 95 9 1155 1160 (Pubitemid 44658477)
    • (2006) British Journal of Cancer , vol.95 , Issue.9 , pp. 1155-1160
    • Brandes, A.A.1    Tosoni, A.2    Cavallo, G.3    Bertorelle, R.4    Gioia, V.5    Franceschi, E.6    Biscuola, M.7    Blatt, V.8    Crino, L.9    Ermani, M.10
  • 25
    • 55749094160 scopus 로고    scopus 로고
    • Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: The "rescue" approach
    • Perry J. R., Rizek P., Cashman R., Morrison M., Morrison T., Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach Cancer 2008 113 8 2152 2157
    • (2008) Cancer , vol.113 , Issue.8 , pp. 2152-2157
    • Perry, J.R.1    Rizek, P.2    Cashman, R.3    Morrison, M.4    Morrison, T.5
  • 28
    • 0033231490 scopus 로고    scopus 로고
    • Immune privilege: Keeping an eye on natural killer T cells
    • DOI 10.1084/jem.190.9.1197
    • Hong S., Van Kaer L., Immune privilege: keeping an eye on natural killer T cells The Journal of Experimental Medicine 1999 190 9 1197 1200 (Pubitemid 29522204)
    • (1999) Journal of Experimental Medicine , vol.190 , Issue.9 , pp. 1197-1200
    • Hong, S.1    Van Kaer, L.2
  • 30
    • 79959949897 scopus 로고    scopus 로고
    • Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer
    • Thara E., Dorff T. B., Pinski J. K., Quinn D. I., Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer Maturitas 2011 69 4 296 303
    • (2011) Maturitas , vol.69 , Issue.4 , pp. 296-303
    • Thara, E.1    Dorff, T.B.2    Pinski, J.K.3    Quinn, D.I.4
  • 31
    • 0022641036 scopus 로고
    • Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: Phase I trial
    • 4 II
    • Jacobs S. K., Wilson D. J., Kornblith P. L., Grimm E. A., Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial Cancer Research 1986 46 4 2101 2104 (Pubitemid 16117915)
    • (1986) Cancer Research , vol.46 , pp. 2101-2104
    • Jacobs, S.K.1    Wilson, D.J.2    Kornblith, P.L.3    Grimm, E.A.4
  • 32
    • 0023813406 scopus 로고
    • Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2
    • Merchant R. E., Grant A. J., Merchant L. H., Young H. F., Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2 Cancer 1988 62 4 665 671
    • (1988) Cancer , vol.62 , Issue.4 , pp. 665-671
    • Merchant, R.E.1    Grant, A.J.2    Merchant, L.H.3    Young, H.F.4
  • 34
    • 0025974603 scopus 로고
    • Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy
    • Lillehei K. O., Mitchell D. H., Johnson S. D., McCleary E. L., Kruse C. A., Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy Neurosurgery 1991 28 1 16 23
    • (1991) Neurosurgery , vol.28 , Issue.1 , pp. 16-23
    • Lillehei, K.O.1    Mitchell, D.H.2    Johnson, S.D.3    McCleary, E.L.4    Kruse, C.A.5
  • 35
    • 0027314032 scopus 로고
    • Therapy of recurrent high grade gliomas with surgery, and autologous mitogen activated IL-2 stimulated killer (MAK) lymphocytes: I. Enhancement of MAK lytic activity and cytokine production by PHA and clinical use of PHA
    • Jeffes E. W. B. III, Beamer Y. B., Jacques S., Silberman R. S., Vayuvegula B., Gupta S., Coss J. S., Yamamoto R. S., Granger G. A., Therapy of recurrent high grade gliomas with surgery, and autologous mitogen activated IL-2 stimulated killer (MAK) lymphocytes: I. Enhancement of MAK lytic activity and cytokine production by PHA and clinical use of PHA Journal of Neuro-Oncology 1993 15 2 141 155 (Pubitemid 23136029)
    • (1993) Journal of Neuro-Oncology , vol.15 , Issue.2 , pp. 141-155
    • Jeffes III, E.W.B.1    Beamer, Y.B.2    Jacques, S.3    Silberman, R.S.4    Vayuvegula, B.5    Gupta, S.6    Coss, J.S.7    Yamamoto, R.S.8    Granger, G.A.9
  • 37
    • 0028108663 scopus 로고
    • Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients
    • Boiardi A., Silvani A., Adelchi Ruffini P., Rivoltini L., Parmiani G., Broggi G., Salmaggi A., Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients Cancer Immunology Immunotherapy 1994 39 3 193 197 (Pubitemid 24298394)
    • (1994) Cancer Immunology Immunotherapy , vol.39 , Issue.3 , pp. 193-197
    • Boiardi, A.1    Silvani, A.2    Adelchi Ruffini, P.3    Rivoltini, L.4    Parmiani, G.5    Broggi, G.6    Salmaggi, A.7
  • 38
  • 39
    • 0030065695 scopus 로고
    • Adoptive immimotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrentmalignant primary brain tumors
    • Sankhla S. K., Nadkarni J. S., Bhagwati S. N., Adoptive immimotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrentmalignant primary brain tumors Journal of Neuro-Oncology 1995 27 2 133 140
    • (1995) Journal of Neuro-Oncology , vol.27 , Issue.2 , pp. 133-140
    • Sankhla, S.K.1    Nadkarni, J.S.2    Bhagwati, S.N.3
  • 43
    • 0030034580 scopus 로고    scopus 로고
    • Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with Grade III/IV astrocytoma
    • Holladay F. P., Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with Grade III/IV astrocytoma Journal of Neuro-Oncology 1996 27 2 179 189 (Pubitemid 26052654)
    • (1996) Journal of Neuro-Oncology , vol.27 , Issue.2 , pp. 179-189
    • Holladay, F.P.1
  • 46
    • 0033781501 scopus 로고    scopus 로고
    • A pilot study of autologous cancer cell vaccination and cellular immunotherapy using anti-CD3 stimulated lymphocytes in patients with recurrent grade III/IV astrocytoma
    • Wood G. W., Holladay F. P., Turner T., Wang Y. Y., Chiga M., A pilot study of autologous cancer cell vaccination and cellular immunotherapy using anti-CD3 stimulated lymphocytes in patients with recurrent grade III/IV astrocytoma Journal of Neuro-Oncology 2000 48 2 113 120
    • (2000) Journal of Neuro-Oncology , vol.48 , Issue.2 , pp. 113-120
    • Wood, G.W.1    Holladay, F.P.2    Turner, T.3    Wang, Y.Y.4    Chiga, M.5
  • 47
    • 33746816721 scopus 로고    scopus 로고
    • Adoptive immunotherapy in patients with recurrent malignant glioma: Preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes
    • Sloan A. E., Dansey R., Zamorano L., Barger G., Hamm C., Diaz F., Baynes R., Wood G., Adoptive immunotherapy in patients with recurrent malignant glioma: preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes Neurosurgical Focus 2000 9 6 e9
    • (2000) Neurosurgical Focus , vol.9 , Issue.6 , pp. 9
    • Sloan, A.E.1    Dansey, R.2    Zamorano, L.3    Barger, G.4    Hamm, C.5    Diaz, F.6    Baynes, R.7    Wood, G.8
  • 48
    • 0030694252 scopus 로고    scopus 로고
    • Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2
    • DOI 10.1007/s002620050405
    • Kruse C. A., Cepeda L., Owens B., Johnson S. D., Stears J., Lillehei K. O., Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2 Cancer Immunology Immunotherapy 1997 45 2 77 87 (Pubitemid 27497682)
    • (1997) Cancer Immunology Immunotherapy , vol.45 , Issue.2 , pp. 77-87
    • Kruse, C.A.1    Cepeda, L.2    Owens, B.3    Johnson, S.D.4    Stears, J.5    Lillehei, K.O.6
  • 49
    • 0033506158 scopus 로고    scopus 로고
    • Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas
    • DOI 10.1023/A:1006293606710
    • Quattrocchi K. B., Miller C. H., Cush S., Bernard S. A., Dull S. T., Smith M., Gudeman S., Varia M. A., Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas Journal of Neuro-Oncology 1999 45 2 141 157 (Pubitemid 30197728)
    • (1999) Journal of Neuro-Oncology , vol.45 , Issue.2 , pp. 141-157
    • Quattrocchi, K.B.1    Miller, C.H.2    Cush, S.3    Bernard, S.A.4    Dull, S.T.5    Smith, M.6    Gudeman, S.7    Varia, M.A.8
  • 50
    • 37549047236 scopus 로고    scopus 로고
    • Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics
    • DOI 10.1007/s00262-007-0387-z
    • Kronik N., Kogan Y., Vainstein V., Agur Z., Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics Cancer Immunology, Immunotherapy 2008 57 3 425 439 (Pubitemid 50007307)
    • (2008) Cancer Immunology, Immunotherapy , vol.57 , Issue.3 , pp. 425-439
    • Kronik, N.1    Kogan, Y.2    Vainstein, V.3    Agur, Z.4
  • 52
    • 0034784610 scopus 로고    scopus 로고
    • Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme
    • DOI 10.1023/A:1011856406683
    • Schneider T., Gerhards R., Kirches E., Firsching R., Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme Journal of Neuro-Oncology 2001 53 1 39 46 (Pubitemid 32936658)
    • (2001) Journal of Neuro-Oncology , vol.53 , Issue.1 , pp. 39-46
    • Schneider, T.1    Gerhards, R.2    Kirches, E.3    Firsching, R.4
  • 53
    • 0035871490 scopus 로고    scopus 로고
    • Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas
    • Andrews D. W., Resnicoff M., Flanders A. E., Kenyon L., Curtis M., Merli G., Baserga R., Iliakis G., Aiken R. D., Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas Journal of Clinical Oncology 2001 19 8 2189 2200 (Pubitemid 32366973)
    • (2001) Journal of Clinical Oncology , vol.19 , Issue.8 , pp. 2189-2200
    • Andrews, D.W.1    Resnicoff, M.2    Flanders, A.E.3    Kenyon, L.4    Curtis, M.5    Merli, G.6    Baserga, R.7    Iliakis, G.8    Aiken, R.D.9
  • 54
    • 0043065333 scopus 로고    scopus 로고
    • Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: Preliminary observations in a patient with a favorable response to therapy
    • DOI 10.1023/A:1024969422010
    • Okada H., Lieberman F. S., Edington H. D., Witham T. F., Wargo M. J., Cai Q., Elder E. H., Whiteside T. L., Schold S. C., Pollack I. F., Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy Journal of Neuro-Oncology 2003 64 1-2 13 20 (Pubitemid 36992456)
    • (2003) Journal of Neuro-Oncology , vol.64 , Issue.1-2 , pp. 13-20
    • Okada, H.1    Lieberman, F.S.2    Edington, H.D.3    Witham, T.F.4    Wargo, M.J.5    Cai, Q.6    Elder, E.H.7    Whiteside, T.L.8    Schold Jr., S.C.9    Pollack, I.F.10
  • 56
    • 33646860113 scopus 로고    scopus 로고
    • Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas
    • DOI 10.1007/s11060-005-9058-0
    • Parney I. F., Chang L. J., Farr-Jones M. A., Hao C., Smylie M., Petruk K. C., Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas Journal of Neuro-Oncology 2006 78 1 71 80 (Pubitemid 43786663)
    • (2006) Journal of Neuro-Oncology , vol.78 , Issue.1 , pp. 71-80
    • Parney, I.F.1    Chang, L.-J.2    Farr-Jones, M.A.3    Hao, C.4    Smylie, M.5    Petruk, K.C.6
  • 57
    • 34347238993 scopus 로고    scopus 로고
    • Clinical trial of autologous formalin-fixed tumor vaccine for glioblastoma multiforme patients
    • DOI 10.1111/j.1349-7006.2007.00518.x
    • Ishikawa E., Tsuboi K., Yamamoto T., Muroi A., Takano S., Enomoto T., Matsumura A., Ohno T., Clinical trial of autologous formalin-fixed tumor vaccine for glioblastoma multiforme patients Cancer Science 2007 98 8 1226 1233 (Pubitemid 46993543)
    • (2007) Cancer Science , vol.98 , Issue.8 , pp. 1226-1233
    • Ishikawa, E.1    Tsuboi, K.2    Yamamoto, T.3    Muroi, A.4    Takano, S.5    Enomoto, T.6    Matsumura, A.7    Ohno, T.8
  • 58
    • 77952548405 scopus 로고    scopus 로고
    • Autologous tumor cell vaccination plus infusion of GM-CSF by a programmable pump in the treatment of recurrent malignant gliomas
    • Clavreul A., Piard N., Tanguy J. Y., Gamelin E., Rousselet M. C., Leynia P., Menei P., Autologous tumor cell vaccination plus infusion of GM-CSF by a programmable pump in the treatment of recurrent malignant gliomas Journal of Clinical Neuroscience 2010 17 7 842 848
    • (2010) Journal of Clinical Neuroscience , vol.17 , Issue.7 , pp. 842-848
    • Clavreul, A.1    Piard, N.2    Tanguy, J.Y.3    Gamelin, E.4    Rousselet, M.C.5    Leynia, P.6    Menei, P.7
  • 60
    • 34848837386 scopus 로고    scopus 로고
    • Taking dendritic cells into medicine
    • DOI 10.1038/nature06175, PII NATURE06175
    • Steinman R. M., Banchereau J., Taking dendritic cells into medicine Nature 2007 449 7161 419 426 (Pubitemid 47509552)
    • (2007) Nature , vol.449 , Issue.7161 , pp. 419-426
    • Steinman, R.M.1    Banchereau, J.2
  • 61
    • 79951978155 scopus 로고    scopus 로고
    • Induction of CD8 + T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with -type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma
    • Okada H., Kalinski P., Ueda R., Induction of CD8 + T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with -type 1 polarized dendritic cells and polyinosinic- polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma Journal of Clinical Oncology 2011 29 3 330 336
    • (2011) Journal of Clinical Oncology , vol.29 , Issue.3 , pp. 330-336
    • Okada, H.1    Kalinski, P.2    Ueda, R.3
  • 62
    • 79952711945 scopus 로고    scopus 로고
    • Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy
    • Prins R. M., Soto H., Konkankit V., Odesa S. K., Eskin A., Yong W. H., Nelson S. F., Liau L. M., Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy Clinical Cancer Research 2011 17 6 1603 1615
    • (2011) Clinical Cancer Research , vol.17 , Issue.6 , pp. 1603-1615
    • Prins, R.M.1    Soto, H.2    Konkankit, V.3    Odesa, S.K.4    Eskin, A.5    Yong, W.H.6    Nelson, S.F.7    Liau, L.M.8
  • 69
    • 23044479028 scopus 로고    scopus 로고
    • Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
    • DOI 10.1158/1078-0432.CCR-05-0464
    • Liau L. M., Prins R. M., Kiertscher S. M., Odesa S. K., Kremen T. J., Giovannone A. J., Lin J. W., Chute D. J., Mischet P. S., Cloughesy T. F., Roth M. D., Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment Clinical Cancer Research 2005 11 15 5515 5525 (Pubitemid 41060828)
    • (2005) Clinical Cancer Research , vol.11 , Issue.15 , pp. 5515-5525
    • Liau, L.M.1    Prins, R.M.2    Kiertscher, S.M.3    Odesa, S.K.4    Kremen, T.J.5    Giovannone, A.J.6    Lin, J.-W.7    Chute, D.J.8    Mischet, P.S.9    Cloughesy, T.F.10    Roth, M.D.11
  • 70
    • 3142692559 scopus 로고    scopus 로고
    • Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
    • DOI 10.1158/0008-5472.CAN-03-3505
    • Yu J. S., Liu G., Ying H., Yong W. H., Black K. L., Wheeler C. J., Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma Cancer Research 2004 64 14 4973 4979 (Pubitemid 38924545)
    • (2004) Cancer Research , vol.64 , Issue.14 , pp. 4973-4979
    • Yu, J.S.1    Liu, G.2    Ying, H.3    Yong, W.H.4    Black, K.L.5    Wheeler, C.J.6
  • 71
    • 7444220033 scopus 로고    scopus 로고
    • Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12
    • Kikuchi T., Akasaki Y., Abe T., Fukuda T., Saotome H., Ryan J. L., Kufe D. W., Ohno T., Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12 Journal of Immunotherapy 2004 27 6 452 459 (Pubitemid 39447353)
    • (2004) Journal of Immunotherapy , vol.27 , Issue.6 , pp. 452-459
    • Kikuchi, T.1    Akasaki, Y.2    Abe, T.3    Fukuda, T.4    Saotome, H.5    Ryan, J.L.6    Kufe, D.W.7    Ohno, T.8
  • 72
    • 4344560470 scopus 로고    scopus 로고
    • Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer
    • DOI 10.1215/S1152851703000668
    • Caruso D. A., Orme L. M., Neale A. M., Radcliff F. J., Armor G. M., Maixner W., Downie P., Hassall T. E., Tang M. L. K., Ashley D. M., Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer Neuro-Oncology 2004 6 3 236 246 (Pubitemid 39136507)
    • (2004) Neuro-Oncology , vol.6 , Issue.3 , pp. 236-246
    • Caruso, D.A.1    Orme, L.M.2    Neale, A.M.3    Radcliff, F.J.4    Armor, G.M.5    Maixner, W.6    Downie, P.7    Hassall, T.E.8    Tang, M.L.K.9    Ashley, D.M.10
  • 73
    • 4143103624 scopus 로고    scopus 로고
    • Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
    • DOI 10.1158/1078-0432.CCR-04-0497
    • Wheeler C. J., Das A., Liu G., Yu J. S., Black K. L., Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination Clinical Cancer Research 2004 10 16 5316 5326 (Pubitemid 39100466)
    • (2004) Clinical Cancer Research , vol.10 , Issue.16 , pp. 5316-5326
    • Wheeler, C.J.1    Das, A.2    Liu, G.3    Yu, J.S.4    Black, K.L.5
  • 74
    • 0242329784 scopus 로고    scopus 로고
    • Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: Results of a clinical phase I/II trial
    • DOI 10.1038/sj.bjc.6601268
    • Yamanaka R., Abe T., Yajima N., Tsuchiya N., Homma J., Kobayashi T., Narita M., Takahashi M., Tanaka R., Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial British Journal of Cancer 2003 89 7 1172 1179 (Pubitemid 37363398)
    • (2003) British Journal of Cancer , vol.89 , Issue.7 , pp. 1172-1179
    • Yamanaka, R.1    Abe, T.2    Yajima, N.3    Tsuchiya, N.4    Homma, J.5    Kobayashi, T.6    Narita, M.7    Takahashi, M.8    Tanaka, R.9
  • 76
    • 0142179258 scopus 로고    scopus 로고
    • + T Cell Production Strongly Influences Tumor Antigen Recognition and Age-Dependent Glioma Mortality
    • Wheeler C. J., Black K. L., Liu G., Thymic CD8 + T cell production strongly influences tumor antigen recognition and age-dependent glioma mortality The Journal of Immunology 2003 171 9 4927 4933 (Pubitemid 37310617)
    • (2003) Journal of Immunology , vol.171 , Issue.9 , pp. 4927-4933
    • Wheeler, C.J.1    Black, K.L.2    Liu, G.3    Ying, H.4    Yu, J.S.5    Zhang, W.6    Lee, P.K.7
  • 80
    • 0030890836 scopus 로고    scopus 로고
    • Cancer vaccines based on the identification of genes encoding cancer regression antigens
    • DOI 10.1016/S0167-5699(97)84664-6, PII S0167569997010219
    • Rosenberg S. A., Cancer vaccines based on the identification of genes encoding cancer regression antigens Immunology Today 1997 18 4 175 182 (Pubitemid 27192179)
    • (1997) Immunology Today , vol.18 , Issue.4 , pp. 175-182
    • Rosenberg, S.A.1
  • 81
    • 0034919646 scopus 로고    scopus 로고
    • The role of MHC class II-restricted tumor antigens and CD4 + T cells in antitumor immunity
    • Wang R. F., The role of MHC class II-restricted tumor antigens and CD4 + T cells in antitumor immunity Trends in Immunology 2001 22 5 269 276
    • (2001) Trends in Immunology , vol.22 , Issue.5 , pp. 269-276
    • Wang, R.F.1
  • 87
    • 33845646732 scopus 로고    scopus 로고
    • Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11
    • DOI 10.1016/j.canlet.2006.01.014, PII S0304383506000620
    • Schmitz M., Wehner R., Stevanovic S., Kiessling A., Rieger M. A., Temme A., Bachmann M., Rieber E. P., Weigle B., Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11 Cancer Letters 2007 245 1-2 331 336 (Pubitemid 44959365)
    • (2007) Cancer Letters , vol.245 , Issue.1-2 , pp. 331-336
    • Schmitz, M.1    Wehner, R.2    Stevanovic, S.3    Kiessling, A.4    Rieger, M.A.5    Temme, A.6    Bachmann, M.7    Rieber, E.P.8    Weigle, B.9
  • 88
    • 3142710121 scopus 로고    scopus 로고
    • HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells
    • DOI 10.1158/0008-5472.CAN-03-3504
    • Liu G., Ying H., Zeng G., Wheeler C. J., Black K. L., Yu J. S., HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells Cancer Research 2004 64 14 4980 4986 (Pubitemid 38924546)
    • (2004) Cancer Research , vol.64 , Issue.14 , pp. 4980-4986
    • Liu, G.1    Ying, H.2    Zeng, G.3    Wheeler, C.J.4    Black, K.L.5    Yu, J.S.6
  • 89
    • 33845698912 scopus 로고    scopus 로고
    • Expression of nine tumour antigens in a series of human glioblastoma multiforme: Interest of EGFRvIII, IL-13Rα2, gp100 and TRP-2 for immunotherapy
    • DOI 10.1007/s11060-006-9220-3
    • Saikali S., Avril T., Collet B., Hamlat A., Bansard J. Y., Drenou B., Guegan Y., Quillien V., Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13R 2, gp100 and TRP-2 for immunotherapy Journal of Neuro-Oncology 2007 81 2 139 148 (Pubitemid 44963972)
    • (2007) Journal of Neuro-Oncology , vol.81 , Issue.2 , pp. 139-148
    • Saikali, S.1    Avril, T.2    Collet, B.3    Hamlat, A.4    Bansard, J.-Y.5    Drenou, B.6    Guegan, Y.7    Quillien, V.8
  • 93
    • 0033049977 scopus 로고    scopus 로고
    • Expression of MAGE and GAGE in high-grade brain tumors: A potential target for specific immunotherapy and diagnostic markers
    • Scarcella D. L., Chow C. W., Gonzales M. F., Economou C., Brasseur F., Ashley D. M., Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers Clinical Cancer Research 1999 5 2 335 341 (Pubitemid 29085187)
    • (1999) Clinical Cancer Research , vol.5 , Issue.2 , pp. 335-341
    • Scarcella, D.L.1    Chow, C.W.2    Gonzales, M.F.3    Economou, C.4    Brasseur, F.5    Ashley, D.M.6
  • 94
    • 80054689372 scopus 로고    scopus 로고
    • MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing
    • Bao L., Dunham K., Lucas K., MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing Cancer Immunology, Immunotherapy 2011 60 9 1299 1307
    • (2011) Cancer Immunology, Immunotherapy , vol.60 , Issue.9 , pp. 1299-1307
    • Bao, L.1    Dunham, K.2    Lucas, K.3
  • 96
    • 4344706290 scopus 로고    scopus 로고
    • AIM-2: A novel tumor antigen is expressed and presented by human glioma cells
    • Liu G., Yu J. S., Zeng G., Yin D., Xie D., Black K. L., Ying H., AIM-2: a novel tumor antigen is expressed and presented by human glioma cells Journal of Immunotherapy 2004 27 3 220 226 (Pubitemid 39118086)
    • (2004) Journal of Immunotherapy , vol.27 , Issue.3 , pp. 220-226
    • Liu, G.1    Yu, J.S.2    Zeng, G.3    Yin, D.4    Xie, D.5    Black, K.L.6    Ying, H.7
  • 97
    • 77950461492 scopus 로고    scopus 로고
    • Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: A medical hypothesis paper
    • Driggers L., Zhang J. G., Newcomb E. W., Ge L., Hoa N., Jadus M. R., Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper Journal of Neuro-Oncology 2010 97 2 159 169
    • (2010) Journal of Neuro-Oncology , vol.97 , Issue.2 , pp. 159-169
    • Driggers, L.1    Zhang, J.G.2    Newcomb, E.W.3    Ge, L.4    Hoa, N.5    Jadus, M.R.6
  • 98
    • 69249149701 scopus 로고    scopus 로고
    • Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens
    • Xu Q., Liu G., Yuan X., Xu M., Wang H., Ji J., Konda B., Black K. L., Yu J. S., Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens Stem Cells 2009 27 8 1734 1740
    • (2009) Stem Cells , vol.27 , Issue.8 , pp. 1734-1740
    • Xu, Q.1    Liu, G.2    Yuan, X.3    Xu, M.4    Wang, H.5    Ji, J.6    Konda, B.7    Black, K.L.8    Yu, J.S.9
  • 100
    • 0035360795 scopus 로고    scopus 로고
    • Cyclooxygenase-2 expression in human gliomas: Prognostic significance and molecular correlations
    • Shono T., Tofilon P. J., Bruner J. M., Owolabi O., Lang F. F., Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations Cancer Research 2001 61 11 4375 4381 (Pubitemid 32685762)
    • (2001) Cancer Research , vol.61 , Issue.11 , pp. 4375-4381
    • Shono, T.1    Tofilon, P.J.2    Bruner, J.M.3    Owolabi, O.4    Lang, F.F.5
  • 103
    • 77953125390 scopus 로고    scopus 로고
    • Influence of Etoposide on anti-apoptotic and multidrug resistance-associated protein genes in CD133 positive U251 glioblastoma stem-like cells
    • Jin F., Zhao L., Guo Y. J., Zhao W. J., Zhang H., Wang H. T., Shao T., Zhang S. L., Wei Y. J., Feng J., Jiang X. B., Zhao H. Y., Influence of Etoposide on anti-apoptotic and multidrug resistance-associated protein genes in CD133 positive U251 glioblastoma stem-like cells Brain Research 2010 1336 103 111
    • (2010) Brain Research , vol.1336 , pp. 103-111
    • Jin, F.1    Zhao, L.2    Guo, Y.J.3    Zhao, W.J.4    Zhang, H.5    Wang, H.T.6    Shao, T.7    Zhang, S.L.8    Wei, Y.J.9    Feng, J.10    Jiang, X.B.11    Zhao, H.Y.12
  • 105
    • 79955813838 scopus 로고    scopus 로고
    • Neuroepithelial stem cell marker nestin regulates the migration, invasion and growth of human gliomas
    • Ishiwata T., Teduka K., Yamamoto T., Kawahara K., Matsuda Y., Naito Z., Neuroepithelial stem cell marker nestin regulates the migration, invasion and growth of human gliomas Oncology Reports 2011 26 1 91 99
    • (2011) Oncology Reports , vol.26 , Issue.1 , pp. 91-99
    • Ishiwata, T.1    Teduka, K.2    Yamamoto, T.3    Kawahara, K.4    Matsuda, Y.5    Naito, Z.6
  • 108
    • 0029895337 scopus 로고    scopus 로고
    • Intracellular localization of cyclin B1 during the cell cycle in glioma cells
    • DOI 10.1002/(SICI)1097-0320(19960501)24:1<49::AID-CYTO6>3.0.CO;2-D
    • Kakino S., Sasaki K., Kurose A., Ito H., Intracellular localization of cyclin B1 during the cell cycle in glioma cells Cytometry 1996 24 1 49 54 (Pubitemid 26169928)
    • (1996) Cytometry , vol.24 , Issue.1 , pp. 49-54
    • Kakino, S.1    Sasaki, K.2    Kurose, A.3    Ito, H.4
  • 110
    • 70949087325 scopus 로고    scopus 로고
    • Gli1 is a potential target for alleviating multidrug resistance of gliomas
    • Cui D., Xu Q., Wang K., Che X., Gli1 is a potential target for alleviating multidrug resistance of gliomas Journal of the Neurological Sciences 2010 288 1-2 156 166
    • (2010) Journal of the Neurological Sciences , vol.288 , Issue.12 , pp. 156-166
    • Cui, D.1    Xu, Q.2    Wang, K.3    Che, X.4
  • 111
    • 79951847980 scopus 로고    scopus 로고
    • Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes
    • Senetta R., Miracco C., Lanzafame S., Chiusa L., Caltabiano R., Galia A., Stella G., Cassoni P., Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes Neuro-Oncology 2011 13 2 176 183
    • (2011) Neuro-Oncology , vol.13 , Issue.2 , pp. 176-183
    • Senetta, R.1    Miracco, C.2    Lanzafame, S.3    Chiusa, L.4    Caltabiano, R.5    Galia, A.6    Stella, G.7    Cassoni, P.8
  • 113
    • 84863241037 scopus 로고    scopus 로고
    • Expression of CD74 in high grade gliomas: A potential role in temozolomide resistance
    • Kitange G. J., Carlson B. L., Schroeder M. A., Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance Journal of Neuro-Oncology 2010 100 2 177 186
    • (2010) Journal of Neuro-Oncology , vol.100 , Issue.2 , pp. 177-186
    • Kitange, G.J.1    Carlson, B.L.2    Schroeder, M.A.3
  • 115
    • 27644466229 scopus 로고    scopus 로고
    • EphA2 as a novel molecular marker and target in glioblastoma multiforme
    • DOI 10.1158/1541-7786.MCR-05-0056
    • Wykosky J., Gibo D. M., Stanton C., Debinski W., EphA2 as a novel molecular marker and target in glioblastoma multiforme Molecular Cancer Research 2005 3 10 541 551 (Pubitemid 41567273)
    • (2005) Molecular Cancer Research , vol.3 , Issue.10 , pp. 541-551
    • Wykosky, J.1    Gibo, D.M.2    Stanton, C.3    Debinski, W.4
  • 116
    • 40749096452 scopus 로고    scopus 로고
    • Interleukin-13 receptor α2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy
    • DOI 10.1158/1078-0432.CCR-07-1990
    • Wykosky J., Gibo D. M., Stanton C., Debinski W., Interleukin-13 receptor 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy Clinical Cancer Research 2008 14 1 199 208 (Pubitemid 351377996)
    • (2008) Clinical Cancer Research , vol.14 , Issue.1 , pp. 199-208
    • Wykosky, J.1    Gibo, D.M.2    Stanton, C.3    Debinski, W.4
  • 117
    • 12344329570 scopus 로고    scopus 로고
    • 2) expression and intermediary filaments in astrocytic tumors
    • Mennel H. D., Lell B., Ganglioside (GD2) expression and intermediary filaments in astrocytic tumors Clinical Neuropathology 2005 24 1 13 18 (Pubitemid 40128782)
    • (2005) Clinical Neuropathology , vol.24 , Issue.1 , pp. 13-18
    • Mennel, H.D.1    Lell, B.2
  • 119
    • 77950460434 scopus 로고    scopus 로고
    • Distribution, cellular localization, and therapeutic potential of the tumor-associated antigen Ku70/80 in glioblastoma multiforme
    • Persson O., Salford L. G., Fransson J., Widegren B., Borrebaeck C. A. K., Holmqvist B., Distribution, cellular localization, and therapeutic potential of the tumor-associated antigen Ku70/80 in glioblastoma multiforme Journal of Neuro-Oncology 2010 97 2 207 215
    • (2010) Journal of Neuro-Oncology , vol.97 , Issue.2 , pp. 207-215
    • Persson, O.1    Salford, L.G.2    Fransson, J.3    Widegren, B.4    Borrebaeck, C.A.K.5    Holmqvist, B.6
  • 122
    • 34548680319 scopus 로고    scopus 로고
    • Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B-induced gliomagenesis
    • DOI 10.1158/1541-7786.MCR-07-0113
    • Ferletta M., Uhrbom L., Olofsson T., Pontén F., Westermark B., Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-Binduced gliomagenesis Molecular Cancer Research 2007 5 9 891 897 (Pubitemid 47416666)
    • (2007) Molecular Cancer Research , vol.5 , Issue.9 , pp. 891-897
    • Ferletta, M.1    Uhrbom, L.2    Olofsson, T.3    Ponten, F.4    Westermark, B.5
  • 123
    • 9144231998 scopus 로고    scopus 로고
    • RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas
    • DOI 10.1038/sj.onc.1207879
    • Gondi C. S., Lakka S. S., Dinh D. H., Olivero W. C., Gujrati M., Rao J. S., RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas Oncogene 2004 23 52 8486 8496 (Pubitemid 39540799)
    • (2004) Oncogene , vol.23 , Issue.52 , pp. 8486-8496
    • Gondi, C.S.1    Lakka, S.S.2    Dinh, D.H.3    Olivero, W.C.4    Gujrati, M.5    Rao, J.S.6
  • 124
    • 33847052535 scopus 로고    scopus 로고
    • Mechanisms of malignant glioma immune resistance and sources of immunosuppression
    • Gomez G. G., Kruse C. A., Mechanisms of malignant glioma immune resistance and sources of immunosuppression Gene Therapy and Molecular Biology 2006 10 1 133 146 (Pubitemid 351976185)
    • (2006) Gene Therapy and Molecular Biology , vol.10 , Issue.1 , pp. 133-146
    • Gomez, G.G.1    Kruse, C.A.2
  • 126
    • 48249102647 scopus 로고    scopus 로고
    • Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate
    • Prins R. M., Cloughesy T. F., Liau L. M., Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate New England Journal of Medicine 2008 359 5 539 541
    • (2008) New England Journal of Medicine , vol.359 , Issue.5 , pp. 539-541
    • Prins, R.M.1    Cloughesy, T.F.2    Liau, L.M.3
  • 127
    • 39149136486 scopus 로고    scopus 로고
    • Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma
    • DOI 10.1215/15228517-2007-035
    • Mitchell D. A., Xie W., Schmittling R., Learn C., Friedman A., McLendon R. E., Sampson J. H., Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma Neuro-Oncology 2008 10 1 10 18 (Pubitemid 351250896)
    • (2008) Neuro-Oncology , vol.10 , Issue.1 , pp. 10-18
    • Mitchell, D.A.1    Xie, W.2    Schmittling, R.3    Learn, C.4    Friedman, A.5    McLendon, R.E.6    Sampson, J.H.7
  • 128
    • 51649111667 scopus 로고    scopus 로고
    • Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation
    • Bao L., Dunham K., Stamer M., Mulieri K. M., Lucas K. G., Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation Biology of Blood and Marrow Transplantation 2008 14 10 1156 1162
    • (2008) Biology of Blood and Marrow Transplantation , vol.14 , Issue.10 , pp. 1156-1162
    • Bao, L.1    Dunham, K.2    Stamer, M.3    Mulieri, K.M.4    Lucas, K.G.5
  • 129
    • 34250869002 scopus 로고    scopus 로고
    • Rapid generation of CMV pp65-specific T cells for immunotherapy
    • DOI 10.1097/CJI.0b013e31803b945b, PII 0000237120070700000010
    • Bao L., Sun Q., Lucas K. G., Rapid generation of CMV pp65-specific T cells for immunotherapy Journal of Immunotherapy 2007 30 5 557 561 (Pubitemid 46988089)
    • (2007) Journal of Immunotherapy , vol.30 , Issue.5 , pp. 557-561
    • Bao, L.1    Sun, Q.2    Lucas, K.G.3
  • 132
    • 27544481941 scopus 로고    scopus 로고
    • A function for interleukin 2 in Foxp3-expressing regulatory T cells
    • DOI 10.1038/ni1263, PII N1263
    • Fontenot J. D., Rasmussen J. P., Gavin M. A., Rudensky A. Y., A function for interleukin 2 in Foxp3-expressing regulatory T cells Nature Immunology 2005 6 11 1142 1151 (Pubitemid 41541792)
    • (2005) Nature Immunology , vol.6 , Issue.11 , pp. 1142-1151
    • Fontenot, J.D.1    Rasmussen, J.P.2    Gavin, M.A.3    Rudensky, A.Y.4
  • 133
    • 33748481603 scopus 로고    scopus 로고
    • An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme
    • DOI 10.1215/15228517-2006-006
    • El Andaloussi A., Lesniak M. S., An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme Neuro-Oncology 2006 8 3 234 243 (Pubitemid 46542648)
    • (2006) Neuro-Oncology , vol.8 , Issue.3 , pp. 234-243
    • El Andaloussi, A.1    Lesniak, M.S.2
  • 136
    • 54949139265 scopus 로고    scopus 로고
    • The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation
    • Annunziato F., Cosmi L., Liotta F., Maggi E., Romagnani S., The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation International Immunology 2008 20 11 1361 1368
    • (2008) International Immunology , vol.20 , Issue.11 , pp. 1361-1368
    • Annunziato, F.1    Cosmi, L.2    Liotta, F.3    Maggi, E.4    Romagnani, S.5
  • 137
  • 139
    • 78149453343 scopus 로고    scopus 로고
    • The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human gliom
    • Wainwright D. A., Sengupta S., Han Y., Ulasov I. V., Lesniak M. S., The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human gliom PLoS ONE 2010 5 10
    • (2010) PLoS ONE , vol.5 , Issue.10
    • Wainwright, D.A.1    Sengupta, S.2    Han, Y.3    Ulasov, I.V.4    Lesniak, M.S.5
  • 141
    • 79960003585 scopus 로고    scopus 로고
    • Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
    • Raychaudhuri B., Rayman P., Ireland J., Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma Neuro-Oncology 2011 13 6 591 599
    • (2011) Neuro-Oncology , vol.13 , Issue.6 , pp. 591-599
    • Raychaudhuri, B.1    Rayman, P.2    Ireland, J.3
  • 143
    • 33845317573 scopus 로고    scopus 로고
    • Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
    • DOI 10.1038/nature05236, PII NATURE05236
    • Bao S., Wu Q., McLendon R. E., Hao Y., Shi Q., Hjelmeland A. B., Dewhirst M. W., Bigner D. D., Rich J. N., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 2006 444 7120 756 760 (Pubitemid 44949604)
    • (2006) Nature , vol.444 , Issue.7120 , pp. 756-760
    • Bao, S.1    Wu, Q.2    McLendon, R.E.3    Hao, Y.4    Shi, Q.5    Hjelmeland, A.B.6    Dewhirst, M.W.7    Bigner, D.D.8    Rich, J.N.9
  • 150
    • 18344375283 scopus 로고    scopus 로고
    • Immunotherapy and chemotherapyapractical partnership
    • Lake R. A., Robinson B. W. S., Immunotherapy and chemotherapyapractical partnership Nature Reviews Cancer 2005 5 5 397 405
    • (2005) Nature Reviews Cancer , vol.5 , Issue.5 , pp. 397-405
    • Lake, R.A.1    Robinson, B.W.S.2
  • 151
    • 33646351049 scopus 로고    scopus 로고
    • Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancer
    • DOI 10.1002/ijc.21681
    • Bourquin C., Schreiber S., Beck S., Hartmann G., Endres S., Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancer International Journal of Cancer 2006 118 11 2790 2795 (Pubitemid 43673358)
    • (2006) International Journal of Cancer , vol.118 , Issue.11 , pp. 2790-2795
    • Bourquin, C.1    Schreiber, S.2    Beck, S.3    Hartmann, G.4    Endres, S.5
  • 152
    • 35948930300 scopus 로고    scopus 로고
    • Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma
    • Kim C. H., Woo S. J., Park J. S., Kim H. S., Park M. Y., Park S. D., Hong Y. K., Kim T. G., Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma Immunology 2007 122 4 615 622
    • (2007) Immunology , vol.122 , Issue.4 , pp. 615-622
    • Kim, C.H.1    Woo, S.J.2    Park, J.S.3    Kim, H.S.4    Park, M.Y.5    Park, S.D.6    Hong, Y.K.7    Kim, T.G.8
  • 153
    • 84863115788 scopus 로고    scopus 로고
    • Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8 + T cells
    • Xu X., Stockhammer F., Schmitt A., Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8 + T cells International Journal of Oncology 40 3 764 772
    • International Journal of Oncology , vol.40 , Issue.3 , pp. 764-772
    • Xu, X.1    Stockhammer, F.2    Schmitt, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.